Showing results (311-320 of 326) with videos related to
Sort By:
Pageof 33
Science Advances|July 12, 2023
GRL-142 binds to and impairs HIV-1 integrase nuclear localization signal and potently suppresses highly INSTI-resistant HIV-1 variantsManabu Aoki, Hiromi Aoki-Ogata, Haydar Bulut, et al.Internal Medicine (Tokyo, Japan)|April 3, 2013
Abacavir/lamivudine versus tenofovir/emtricitabine with atazanavir/ritonavir for treatment-naive Japanese patients with HIV-1 infection: a randomized multicenter trialTakeshi Nishijima, Misao Takano, Michiyo Ishisaka, et al.Iscience|November 7, 2022
Potent and biostable inhibitors of the main protease of SARS-CoV-2Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, et al.Journal of Medicinal Chemistry|September 11, 2025
Azapeptide-Based SARS-CoV-2 Main Protease Inhibitors: Design, Synthesis, Enzyme Inhibition, Structural Determination, and Antiviral ActivityPhilipp Flury, Jyoti Vishwakarma, Katharina Sylvester, et al.Elife|October 18, 2017
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potencyManabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, et al.Nature Communications|January 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replicationShin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, et al.PNAS Nexus|January 20, 2025
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrierNobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi, et al.Nucleic Acids Research|September 13, 2011
Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptaseTanyaradzwa P Ndongwe, Adeyemi O Adedeji, Eleftherios Michailidis, et al.Viruses|December 16, 2020
Comparison of Rapid Antigen Tests for COVID-19Seiya Yamayoshi, Yuko Sakai-Tagawa, Michiko Koga, et al.Eclinicalmedicine|February 16, 2021
Antibody titers against SARS-CoV-2 decline, but do not disappear for several monthsSeiya Yamayoshi, Atsuhiro Yasuhara, Mutsumi Ito, et al.Pageof 33